Literature DB >> 25497695

IBIS-I tamoxifen update: maturity brings questions.

Rowan T Chlebowski1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25497695     DOI： 10.1016/S1470-2045(14)71184-2

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  7 in total

1.  Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials.

Authors:  Rowan T Chlebowski; Garnet L Anderson; Aaron K Aragaki; JoAnn E Manson; Marcia L Stefanick; Kathy Pan; Wendy Barrington; Lewis H Kuller; Michael S Simon; Dorothy Lane; Karen C Johnson; Thomas E Rohan; Margery L S Gass; Jane A Cauley; Electra D Paskett; Maryam Sattari; Ross L Prentice
Journal:  JAMA       Date:  2020-07-28       Impact factor: 56.272

2.  Low-Fat Dietary Pattern and Breast Cancer Mortality in the Women's Health Initiative Randomized Controlled Trial.

Authors:  Rowan T Chlebowski; Aaron K Aragaki; Garnet L Anderson; Cynthia A Thomson; JoAnn E Manson; Michael S Simon; Barbara V Howard; Thomas E Rohan; Linda Snetselar; Dorothy Lane; Wendy Barrington; Mara Z Vitolins; Catherine Womack; Lihong Qi; Lifang Hou; Fridtjof Thomas; Ross L Prentice
Journal:  J Clin Oncol       Date:  2017-06-27       Impact factor: 44.544

3.  Low-fat dietary pattern and breast cancer mortality by metabolic syndrome components: a secondary analysis of the Women's Health Initiative (WHI) randomised trial.

Authors:  Kathy Pan; Aaron K Aragaki; Marian L Neuhouser; Michael S Simon; Juhua Luo; Bette Caan; Linda Snetselaar; Joanne E Mortimer; JoAnn E Manson; Candyce Kroenke; Dorothy Lane; Kerryn Reding; Thomas E Rohan; Rowan T Chlebowski
Journal:  Br J Cancer       Date:  2021-05-18       Impact factor: 7.640

4.  Dietary Modification and Breast Cancer Mortality: Long-Term Follow-Up of the Women's Health Initiative Randomized Trial.

Authors:  Rowan T Chlebowski; Aaron K Aragaki; Garnet L Anderson; Kathy Pan; Marian L Neuhouser; JoAnn E Manson; Cynthia A Thomson; Yasmin Mossavar-Rahmani; Dorothy S Lane; Karen C Johnson; Jean Wactawski-Wende; Linda Snetselaar; Thomas E Rohan; Juhua Luo; Ana Barac; Ross L Prentice
Journal:  J Clin Oncol       Date:  2020-02-07       Impact factor: 50.717

Review 5.  Decision making for breast cancer prevention among women at elevated risk.

Authors:  Tasleem J Padamsee; Celia E Wills; Lisa D Yee; Electra D Paskett
Journal:  Breast Cancer Res       Date:  2017-03-24       Impact factor: 6.466

6.  Understanding low chemoprevention uptake by women at high risk of breast cancer: findings from a qualitative inductive study of women's risk-reduction experiences.

Authors:  Tasleem J Padamsee; Megan Hils; Anna Muraveva
Journal:  BMC Womens Health       Date:  2021-04-16       Impact factor: 2.809

7.  Breast Cancer Prevention: Time for Change.

Authors:  Rowan T Chlebowski; Aaron K Aragaki; Kathy Pan
Journal:  JCO Oncol Pract       Date:  2021-07-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.